Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.48 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.48 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.48 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.48 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.48 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.48 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.48 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.48 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.48 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.48 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.48 |
| ▸ | CTSD | P07339 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | SRC | P12931 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2328390 | 0.81 | TDP1 (0.54) | TDP1L3MBTL1HDAC3HDAC4HDAC1 | |
| SCHEMBL5565862 | 0.77 | POLB (0.50) | TDP1L3MBTL1HDAC3HDAC4HDAC1 | |
| SCHEMBL3448890 | 0.73 | HSD11B1 (0.59) | TDP1L3MBTL1HDAC3HDAC4HDAC1 | |
| SCHEMBL465969 | 0.72 | TDP1 (0.61) | TDP1L3MBTL1HDAC3HDAC4HDAC1 | |
| Diphenylacetic Acid SCHEMBL8513250 | 0.72 | SRC (0.62) | TDP1L3MBTL1HDAC3HDAC4HDAC1 | |
| Diphenylacetic Acid SCHEMBL38022 | 0.72 | SRC (0.62) | TDP1L3MBTL1HDAC3HDAC4HDAC1 | |
| Diphenylacetic Acid SCHEMBL8411440 | 0.70 | SRC (0.59) | TDP1L3MBTL1HDAC3HDAC4HDAC1 | |
| Diphenylacetic Acid SCHEMBL9485695 | 0.70 | SRC (0.59) | TDP1L3MBTL1HDAC3HDAC4HDAC1 | |
| Diphenylacetic Acid SCHEMBL418537 | 0.70 | SRC (0.59) | TDP1L3MBTL1HDAC3HDAC4HDAC1 | |
| SCHEMBL72488 | 0.70 | TDP1 (0.58) | TDP1L3MBTL1HDAC3HDAC4HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119899356-A | Self-healing polyurethane elastomer material based on dynamic reversible covalent bonds, preparation method and seamless telescopic structure based on material | 南京兴佑交通科技有限公司 | 2025-04-29 | — | — | CN | claimed |
| CN-118304462-B | Hemostatic material and preparation method thereof | 安徽皓元药业有限公司 | 2024-08-16 | — | — | CN | claimed |
| CN-118304462-A | Hemostatic material and preparation method thereof | 安徽皓元药业有限公司 | 2024-07-09 | — | — | CN | claimed |
| WO-2026102761-A1 | XDH NUCLEIC ACID-TARGETED OLIGONUCLEOTIDE AND USE THEREOF | 思合基因(北京)生物科技有限公司 | 2026-05-21 | — | — | WO | disclosed |
| CN-122038392-A | Antisense oligonucleotide targeting ACSL4 mRNA and application thereof in preparation of hypolipidemic drugs | 云南大学 | 2026-05-15 | — | — | CN | disclosed |
| CN-122055446-A | IRS-1 mRNA targeting oligonucleotide and application thereof | 思合基因(北京)生物科技有限公司 | 2026-05-15 | — | — | CN | disclosed |
| CN-121045299-A | Oligonucleotide synthesis method | 通用生物(安徽)股份有限公司 | 2025-12-02 | — | — | CN | disclosed |
| CN-119899356-A | Self-healing polyurethane elastomer material based on dynamic reversible covalent bonds, preparation method and seamless telescopic structure based on material | 南京兴佑交通科技有限公司 | 2025-04-29 | — | — | CN | disclosed |
| CN-119876147-A | Oligonucleotides for inhibiting TRPV1 expression, composition and application | 思合基因(北京)生物科技有限公司 | 2025-04-25 | — | — | CN | disclosed |
| CN-119752901-A | CpG oligonucleotide | 浙江天元生物药业有限公司 | 2025-04-04 | — | — | CN | disclosed |
| CN-119662638-A | Double-stranded RNA composition for regulating expression of angiotensinogen AGT and application thereof | 苏州时安生物技术有限公司 | 2025-03-21 | — | — | CN | disclosed |
| WO-2010039088-A1 | CHEMICALLY MODIFIED CELL-PENETRATING PEPTIDES FOR IMPROVED DELIVERY OF GENE MODULATING COMPOUNDS | AHMED KARIEM (SE) | 2010-04-08 | — | — | WO | disclosed |
| US-20100016416-A1 | Oligonucleotide Conjugates | GERON CORPORATION (US) | 2010-01-21 | — | — | US | disclosed |
| US-7563618-B2 | Oligonucleotide conjugates | GERON CORPORATION (US) | 2009-07-21 | — | — | US | disclosed |
| EP-1543021-A2 | OLIGONUCLEOTIDE CONJUGATES | Geron Corporation (US) | 2005-06-22 | — | — | EP | disclosed |
| EP-1379689-A4 | OLIGONUCLEOTIDE CONJUGATES | GERON CORP (US) | 2004-04-14 | — | — | EP | disclosed |
| WO-2004029277-A2 | OLIGONUCLEOTIDE CONJUGATES | GERON CORPORATION (US) | 2004-04-08 | — | — | WO | disclosed |
| EP-1379689-A2 | OLIGONUCLEOTIDE CONJUGATES | Geron Corporation (US) | 2004-01-14 | — | — | EP | disclosed |
| US-20030138814-A1 | Comprises RNA and nucleobase/fluorophore for inhibition of human telomerase activity (inhibits growth of cancerous cells) | GERON CORPORATION | 2003-07-24 | — | — | US | disclosed |
| WO-2002077184-A2 | OLIGONUCLEOTIDE CONJUGATES | GERON CORPORATION (US) | 2002-10-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030138814-A1 | Comprises RNA and nucleobase/fluorophore for inhibition of human telomerase activity (inhibits growth of cancerous cells) | TERT, RNGTT, DUT | TDP1 170/4885L3MBTL1 230/4885HDAC3 1211/4885 |
| US-20100016416-A1 | Oligonucleotide Conjugates | TERT, RNGTT, TRDMT1 | TDP1 51/4885L3MBTL1 318/4885HDAC3 1523/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.